Who is sponsoring NCT03921125?

NCT03921125 is sponsored by Ain Shams University.

What drugs are being tested in NCT03921125?

Interventions in NCT03921125: Massimo for Pleth variability index.

What condition does NCT03921125 study?

NCT03921125 studies Fluid Response.

Is NCT03921125 still recruiting?

NCT03921125 is currently status unknown. Last updated 4 June 2019.

Last reviewed 2019-06-04 · How we verify

NCT03921125

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pleth Variability Index for Directed Fluid Optimization in Donors in Living Donor Liver Transplantation

Status unknown Last updated 4 June 2019

What this trial tests

trial testing Massimo for Pleth variability index in Fluid Response in 40 participants. Status unknown.

Timeline

9 October 2018

Primary endpoint
20 September 2019

20 October 2019

Quick facts

Lead sponsor	Ain Shams University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	40
Start date	9 October 2018
Primary completion	20 September 2019
Estimated completion	20 October 2019
Sites	2 locations across Egypt

Drugs / interventions tested

Massimo for Pleth variability index

Conditions studied

Fluid Response — all drugs for Fluid Response →

Sponsor

Ain Shams University

Who can join

Adults 20 to 40, any sex, with Fluid Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this Study we are trying to validate the accuracy of Plethogram variability index in predicting fluid responsiveness compared to pulse pressure variation in donors of liver transplantation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03921125 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 4 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03921125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing